Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
01 April, 2015 23:19 IST
`Buy` Cadila Healthcare; target Rs 866: Angel Broking
Source: IRIS Exclusive | 09 Feb, 2012, 04.54PM
Comments  |  Post Comment

Angel Broking  has recommended `Buy` on Cadila Healthcare with a revised price target of Rs 866 as against the current market price (CMP) of Rs 674 in its report dated Feb. 7, 2012. The broking house gave the following rationale:

Cadila Healthcare (Cadila) reported lower-than-expected numbers for 3QFY2012, except on the sales front. The company`s sales for the quarter were mostly in-line at ~Rs 13.52 billion. However, higher R&D expense during the quarter resulted in depression in the operating margin, which came in at 17.1%. This coupled with forex losses during the quarter resulted in higher dip in net profit during the quarter. The stock is trading at 20.1x FY2012E and 15.6x FY2013E earnings. We recommend Buy on the stock. 

Lower-than-expected set of numbers: For 3QFY2012, Cadila reported net sales of Rs 13.52 billion, up 19.2% yoy and higher than our estimate of  Rs 12.78 billion, driven by exports. On the domestic front, net sales grew by 8.4% yoy to  Rs 6.06 billion. The company`s gross margin declined by 66.6% during the quarter. The company`s OPM also declined to 17.1%, majorly due to higher employee expenses and R&D expenses, which grew by 35.1% and 108.3% yoy, respectively. Net profit for the quarter declined by 7.8% yoy to  Rs 1.49 billion (Rs 1.62 billion). Adjusted for forex loss of Rs 343 million, the company posted net profit growth of almost 9.0% yoy, still lower than our estimate of 19.1% yoy growth.

Outlook and valuation: We expect Cadila`s net sales to post a 17.8% CAGR to Rs 61.96 billion and EPS to report an 11.7% CAGR to  Rs 43.3 over FY2011-13E. We recommend Buy on the stock with a revised target price of Rs 866.

Click here to view full report

Disclaimer: IRIS has taken due care and caution in compilation of data for its web site. Information has been obtained by IRIS from sources which it considers reliable. However, IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website.



Cadila Healthcare Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Reliance MF buys 1.07 mn shares in INOX Leisure - 01-Apr-2015 19:37
Piramal sells clinical research division to Indoco - 01-Apr-2015 19:14
SBI approves Rs 29.70 bn preferential allotment of shares to govt - 01-Apr-2015 19:04
Orient Bell to acquire 19.5% equity stake in Gujarat Co - 01-Apr-2015 19:03
SJVN signs MoU with Ministry of Power - 01-Apr-2015 18:58
NTPC authorizes Muzaffarpur thermal power station - 01-Apr-2015 18:47
Sun Pharma settles litigation for generic Angiomax in US - 01-Apr-2015 18:41
TVS Motor March sales grow 7% - 01-Apr-2015 18:30
Tata Motors sales rise 3% in March - 01-Apr-2015 18:22
ONGC Energy Centre gets US Patent on Hydrogen generation process - 01-Apr-2015 18:18
Bharat Electronics registers sales turnover growth of 8% in FY15 - 01-Apr-2015 15:25
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer